Hainan Honz Pharmaceutical filed it has brought all of Hebei Tianhe Pharmaceutical Group’s assets, including 16,900 square meters of property, medicine certificates and copyrights, for 21 million yuan, reports 163.com.
The transaction is supplementary to the firm’s current product mix and will contribute to its pediatric medicine development. The purchase is intended to lower logistic costs.
Hebei Tianhe Pharmaceutical Group was found in 2005 with registered capital of 51.3 million yuan and produces eye drops, granular formulation, syrup, mixtures, and oral solutions.
Editorial Message 
This site contains materials from other clearly stated media sources for the purpose of discussion stimulation and content enrichment among our members only. 

whatsonsanya.com does not necessarily endorse their views or the accuracy of their content. For copyright infringement issues please contact editor@whatsonsanya.com